Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,501
Closed -$3.12M 640
2017
Q2
$3.12M Sell
11,501
-6,900
-37% -$1.82M 0.12% 140
2017
Q1
$5.03M Buy
18,401
+10,601
+136% +$3M 0.04% 351
2016
Q4
$2.21M Sell
7,800
-18,300
-70% -$5.42M 0.01% 854
2016
Q3
$8.17M Sell
26,100
-88,000
-77% -$26.1M 0.04% 353
2016
Q2
$27.6M Buy
114,100
+45,000
+65% +$11.9M 0.13% 135
2016
Q1
$18M Sell
69,100
-24,700
-26% -$6.52M 0.09% 196
2015
Q4
$28.7M Sell
93,800
-127,500
-58% -$36.6M 0.14% 108
2015
Q3
$64.6M Buy
221,300
+139,200
+170% +$46M 0.27% 58
2015
Q2
$33.2M Buy
82,100
+29,700
+57% +$11.9M 0.15% 118
2015
Q1
$22.1M Sell
52,400
-2,300
-4% -$907K 0.1% 176
2014
Q4
$18.6M Buy
54,700
+6,500
+13% +$2.1M 0.07% 214
2014
Q3
$15.9M Sell
48,200
-26,100
-35% -$8.61M 0.07% 238
2014
Q2
$23.4M Sell
74,300
-63,400
-46% -$19.1M 0.11% 149
2014
Q1
$42.1M Buy
137,700
+23,800
+21% +$7.55M 0.18% 78
2013
Q4
$31.8M Sell
113,900
-42,900
-27% -$11.1M 0.11% 124
2013
Q3
$37.8M Sell
156,800
-35,000
-18% -$7.83M 0.13% 112
2013
Q2
$41.3M Buy
+191,800
New +$41M 0.15% 95

Other funds holding BIIB

Timber Hill's BIIB Position: Q2 2018 in Review

Timber Hill sold out of Biogen (BIIB) in Q2 2018, closing a stake of 4,910 shares — an estimated $1.34M sold.

Timber Hill first reported a position in BIIB in Q3 2013 and held it in 10 quarters. The position peaked at $8.47M in Q3 2013. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Timber Hill reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 4,910 Biogen shares in Q2 2018, an estimated $1.34M.
  • Timber Hill first reported a position in Biogen in Q3 2013 and held it in 10 quarters.
  • Timber Hill's Biogen position peaked at $8.47M in Q3 2013.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.